Technetium Tc-99m Sulfur Colloid: Clinical Trials

7 trials of Technetium Tc-99m Sulfur Colloid, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 terminated, 1 not yet recruiting, 1 recruiting. 3 Not applicable, 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable3Terminated 2, Completed 1
Phase 23Completed 2, Recruiting 1
Phase 11Not yet recruiting 1

Follow Technetium Tc-99m Sulfur Colloid: new trials by email Literature Review of Technetium Tc-99m Sulfur Colloid trials Research Report on Technetium Tc-99m Sulfur Colloid

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Escalating Cycle 1 Dose of Lu-177-PSMA-617 for the Treatment of Metastatic Castration Resistant Prostate Cancer
Biospecimen Collection, Computed Tomography, Gallium Ga 68 Gozetotide - Metastatic Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8
Phase 1Not yet recruitingUniversity of Michigan Rogel Cancer Center202026-12-012026-10-15
Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial
Biospecimen Collection, Carboplatin, Cisplatin - Oral Cavity Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Cancer AJCC v8
Phase 2RecruitingUniversity of Michigan Rogel Cancer Center502025-07-172026-07-31
Sulfur Colloid SPECT/CT in Measuring Liver Function in Patients With Primary or Metastatic Liver Cancer Undergoing Radiation Therapy or Surgery
Computed Tomography, Single Photon Emission Computed Tomography, Technetium Tc-99m Sulfur Colloid - Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma
Not applicableTerminatedUniversity of Washington412016-12-212025-10-29
FLARE RT for Patients With Stage IIB-IIIB Non-small Cell Lung Cancer: Personalizing Radiation Therapy Using PET/CT and SPECT/CT Imaging
Computed Tomography, Fludeoxyglucose F-18, Laboratory Biomarker Analysis - Stage IIB Lung Non-Small Cell Carcinoma AJCC v7, Stage IIIA Lung Non-Small Cell Cancer AJCC v7
Phase 2CompletedUniversity of Washington512016-05-202024-08-14
Comparison of Use of Indocyanine Green and 99mTc-labeled Radiotracer for Axillary Lymphatic Mapping in Patients With Breast Cancer
Indocyanine Green Solution, Technetium Tc-99m Sulfur Colloid, Lymphoscintigraphy - Stage I Breast Cancer, Stage II Breast Cancer
Not applicableCompletedCase Comprehensive Cancer Center1022015-02-172022-06-30
Lymph Node Mapping in Finding Metastatic Disease in Patients With Sebaceous Gland Cancer of the Eyelid
Lymph Node Mapping, Sentinel Lymph Node Biopsy, Technetium Tc-99m Sulfur Colloid - Eyelid Sebaceous Gland Carcinoma
Phase 2CompletedM.D. Anderson Cancer Center202009-02-252025-07-04
Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer
Isosulfan Blue, Lymph Node Mapping, Lymphangiography - Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma
Not applicableTerminatedGynecologic Oncology Group1022004-06-012017-11-06

Conditions studied

Breast Neoplasms (1)  ·  Carcinoma, Hepatocellular (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Cholangiocarcinoma (1)  ·  Liver Neoplasms (1)  ·  Mouth Neoplasms (1)  ·  Prostatic Neoplasms (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)  ·  Thrombosis (1)  ·  Uterine Cervical Neoplasms (1)

Sponsors

University of Michigan Rogel Cancer Center (2)  ·  University of Washington (2)  ·  Case Comprehensive Cancer Center (1)  ·  Gynecologic Oncology Group (1)  ·  M.D. Anderson Cancer Center (1)

Countries

United States (7)

Top investigators

Bita M Esmaeli (1)  ·  Charles Levenback (1)  ·  Jennifer L Shah (1)  ·  Jing Zeng (1)  ·  Kirk A Frey, MD (1)  ·  Smith Apisarnthanarax (1)  ·  Stephen Grobmyer, MD (1)

Results publications

PMID 31142507, PMID 33027064, PMID 34172602, PMID 38981590

NIH funding

R01CA204301 (1), R01CA289631 (1), U10CA027469 (1)